Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Gabriel Erdozain

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Medicina Clinica|December 2, 2014
[Metabolic syndrome in patients with systemic lupus erythematosus: causes and consequences]Jose Gabriel Erdozain, Guillermo Ruiz Irastorza
The Journal of Rheumatology|October 3, 2014
Dr. Erdozain, et al replyJose Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
The Journal of Rheumatology|January 17, 2014
Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factorsJose Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
Lupus Science & Medicine|January 27, 2017
Predictors of peripheral arterial disease in SLE change with patient's ageJose-Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
Rheumatology (Oxford, England)|June 13, 2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adultsGuillermo Ruiz-Irastorza, Amaia Ugarte, Ioana Ruiz-Arruza, et al.
Lupus|September 27, 2007
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosusAgustin Martinez-Berriotxoa, Guillermo Ruiz-Irastorza, Maria-Victoria Egurbide, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Ankle-brachial index and arterial vascular events in systemic lupus erythematosus patients: a 5-year prospective cohortJose-Gabriel Erdozain, Jose-Ignacio Pijoan, Irama Villar, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Medicina Clinica|December 2, 2014
[Metabolic syndrome in patients with systemic lupus erythematosus: causes and consequences]Jose Gabriel Erdozain, Guillermo Ruiz Irastorza
The Journal of Rheumatology|October 3, 2014
Dr. Erdozain, et al replyJose Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
The Journal of Rheumatology|January 17, 2014
Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factorsJose Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
Lupus Science & Medicine|January 27, 2017
Predictors of peripheral arterial disease in SLE change with patient's ageJose-Gabriel Erdozain, Irama Villar, Javier Nieto, et al.
Rheumatology (Oxford, England)|June 13, 2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adultsGuillermo Ruiz-Irastorza, Amaia Ugarte, Ioana Ruiz-Arruza, et al.
Lupus|September 27, 2007
Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosusAgustin Martinez-Berriotxoa, Guillermo Ruiz-Irastorza, Maria-Victoria Egurbide, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Ankle-brachial index and arterial vascular events in systemic lupus erythematosus patients: a 5-year prospective cohortJose-Gabriel Erdozain, Jose-Ignacio Pijoan, Irama Villar, et al.
Pageof 1